Tiratricol-induced periodic paralysis: a review of nutraceuticals affecting thyroid function

Endocr Pract. 2011 Jul-Aug;17(4):610-5. doi: 10.4158/EP10137.RA.

Abstract

Objective: To review the potential adverse effects of thyroid hormone-based nutraceuticals and describe a case of thyrotoxic periodic paralysis (TPP) after abuse of a dietary supplement containing 3,5,3'-triiodothyroacetic acid (tiratricol).

Methods: We review the literature on potential dangers and therapeutic misadventures of thyroid hormone-based nutraceuticals and present the clinical, laboratory, and radiologic data of a bodybuilder in whom hypokalemic TPP developed after use of "Triax Metabolic Accelerator".

Results: A 23-year-old white man developed lower extremity paralysis, diaphoresis, and palpitations in the setting of low serum potassium levels. Laboratory results showed suppressed thyroid-stimulating hormone, low levels of free and total thyroxine, low total triiodothyronine level, and very low 24-hour radioiodine uptake. The patient ultimately admitted to taking a supplement containing tiratricol for approximately 2 months, and hypokalemic TPP was diagnosed. He was treated with potassium supplementation and a β-adrenergic blocking agent, which completely resolved his symptoms. Results of thyroid function tests normalized or approached normal 1 week after hospitalization, and future use of dietary supplements was strongly discouraged. Despite 2 warnings by the US Food and Drug Administration, products containing tiratricol are still available for sale on the Internet.

Conclusion: This report illustrates both an unusual adverse effect of a nutraceutical containing tiratricol and the importance of educating our patients about the risks versus benefits of using these widely available but loosely regulated products.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Humans
  • Male
  • Paralysis / chemically induced*
  • Thyroid Function Tests
  • Thyroid Gland / drug effects*
  • Triiodothyronine / adverse effects
  • Triiodothyronine / analogs & derivatives*
  • Young Adult

Substances

  • Triiodothyronine
  • 3,3',5-triiodothyroacetic acid